推销观念

市场营销观念

产品观念

A

B

C

D

E

F

G

EMA defines "gene therapy medicinal products (GTMPs) generally consist of a vector or delivery formulation/system containing a genetic construct engineered to express a specific transgene ('therapeutic sequence') for the regulation, repair, replacement, addition or deletion of a genetic sequence. The active substance is the nucleic acid sequence(s), or genetically modified microorganism(s), virus(es) or cells.

EMA defines that a gene therapy medicinal product is a biological medicinal product.

EMA defines that a gene therapy medicinal product fulfills the following two characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic acid used in or administered to human beings with a view to regulating, repairing, replacing, adding or deleting a genetic sequence; (b) its therapeutic, prophylactic or diagnostic effect relates directly to the recombinant nucleic acid sequence it contains, or to the product of genetic expression of this sequence.

Gene therapy medicinal products shall not include vaccines against infectious diseases.

业务实施方案，包括拟申请业务的管理体系、主要风险及拟采取的管理措施等

商业银行的财务报告

银行负责人签署的申请书

拟申请业务介绍，包括业务性质、目标客户群以及相关分析预测

正确

错误